It’s the simple truth: you can't treat a disease until you diagnose it. Tuberculosis (TB)—even drug-resistant varieties—can usually be cured, but time is of the essence. Until the highly contagious disease is treated, it continues to spread.
India is home to the most TB cases in the world, so containing the disease is a national priority. But diagnosis can be challenging, especially for drug-resistant TB.
The story of Dr. Aparna Srikantam and the Blue Peter Public Health & Research Centre demonstrates the challenges—and the rewards. With funding from the US Agency for International Development (USAID), PATH is expanding diagnostic capacity across India and improving TB laboratory safety. The result: people with TB have a better chance to get the right treatment quickly—before it’s too late.